Publications

Dernière publication 19/06/2023

Efgartigimod restores muscle function in a humanized mouse model of immune-media

Objective: Immune-mediated necrotizing myopathies (IMNMs) are severe forms of myositis often associated with pathogenic...

Array
(
    [id_prestablog_news] => 1844
    [id_shop] => 1
    [date] => 2023-06-19 00:00:00
    [date_modification] => 2024-02-09 14:15:13
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 3394
    [id_lang] => 2
    [title] => Efgartigimod restores muscle function in a humanized mouse model of immune-media
    [paragraph] => Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy
    [content] => 
Authors
Julien S, van der Woning B, De Ceuninck L, Briand E, Jaworski T, Roussel G, Zoubaïri R, Allenbach Y, Benveniste O, Drouot L, Boyer O.

 Lab
Univ Rouen Normandie, Inserm , Rouen, France
Journal
rheumatology
Abstract
Objective: Immune-mediated necrotizing myopathies (IMNMs) are severe forms of myositis often associated with pathogenic anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) autoantibodies (aAbs). Efgartigimod is an engineered human IgG1 Fc fragment that antagonizes the neonatal Fc receptor (FcRn), thereby preventing recycling and promoting lysosomal degradation of IgG, including aAbs. We evaluated the therapeutic effects of IgG reduction by efgartigimod in a humanized murine model of IMNM. Methods Disease was induced in C5-deficient (C5def) or Rag2-deficient (Rag2–/–) mice receiving co-injections of anti-HMGCR+ IgG from an IMNM patient and human complement. C5def mice were treated in a preventive setting with s.c. injections of efgartigimod and Rag2–/– mice in a curative setting after disease was induced by anti-HMGCR+ IgG injections. Anti-HMGCR aAbs levels were monitored in mouse serum and muscle tissue. Histological analysis was performed on muscle sections. Muscle force was assessed by grip test or measurement of gastrocnemius strength upon electrostimulation. Results Administration of efgartigimod rapidly reduced total IgG levels, including the level of pathogenic anti-HMGCR aAbs, in both serum (P < 0.0001) and muscle (P < 0.001). In the preventive setting, efgartigimod prevented myofibre necrosis (P < 0.05), thus precluding loss of muscle strength (P < 0.05). In the therapeutic setting, efgartigimod prevented further necrosis and allowed muscle fibre regeneration (P < 0.05). Hence, muscle strength returned to normal (P < 0.01). Conclusion: Efgartigimod reduces circulating IgG levels, including pathogenic anti-HMGCR+ IgG aAbs, in a humanized mouse model of IMNM, preventing further necrosis and allowing muscle fibre regeneration. These results support investigating the therapeutic efficacy of efgartigimod through a clinical trial in IMNM patients.
BIOSEB Instruments Used
Grip strength test (BIO-GS4)

Keywords/Topics
Déficits moteurs
    [meta_description] => 
    [meta_keywords] => https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/kead298/7202039?login=true
    [meta_title] => 
    [link_rewrite] => efgartigimod-restores-muscle-function-in-a-humanized-mouse-model-of-immune-mediated-necrotizing-myopathy
    [actif_langue] => 1
    [read] => 626
    [count_comments] => 0
    [id] => 1844
    [categories] => Array
        (
            [54] => Array
                (
                    [id_prestablog_categorie] => 54
                    [title] => Déficits moteurs
                    [link_rewrite] => Déficits-moteurs
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Efgartigimod restores muscle function in a humanized mouse model of immune-mediated [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Test d'agrippement
                    [description_short] => 
Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
                )

        )

)
1